Table 2.
Variable | CON (n = 10) | p-value | HI (n = 10) | p-value | BFR (n = 12) | p-value | p-value | |||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Before | After | Before | After | Before | After | Δ Comparisons | ||||
Heart rate variability | ||||||||||
HR (bpm) | 62 ± 10 | 63 ± 8 | 0.40 | 71 ± 11 | 68 ± 14 | 0.28 | 65 ± 10 | 65 ± 10 | 0.47 | 0.76 |
RR interval (ms) | 987.5 ± 160.8 | 964.7 ± 130.4 | 0.28 | 861.3 ± 141.5 | 907.7 ± 163.4 | 0.23 | 938.8 ± 142.4 | 933.8 ± 138.7 | 0.45 | 0.61 |
SDNN (ms) | 23.1 [15.7–50.5] | 18.3 [11.0–40.6] | 0.08 | 23.1 [14.4–33.3] | 19.5 [ 14.0–23.2] | 0.28 | 18.7 [15.5–25.9] | 21.9 [13.5–28.1] | 0.41 | 0.36 |
rMSSD (ms) | 25.2 [14.9–35.8] | 23.7 [10.3–48.1] | 0.19 | 23.7 [13.3–40.0] | 23.1 [13.0–28.8] | 0.43 | 20.9 [13.0–33.8] | 22.7 [14.2–32.0] | 0.47 | 0.95 |
pNN50 (%) | 4.1 [0–14.3] | 3.5 [0–22.0] | 0.26 | 5.6 [0.3–19.8] | 2.1 [0.2–5.5] | 0.30 | 0.8 [0.1–9.3] | 1.5 [0.1–10.6] | 0.25 | 0.63 |
LF (n.u.) | 51.6 ± 24.3 | 49.2 ± 29.4 | 0.35 | 58.5 ± 22.5 | 43.9 ± 22.5 | 0.07 | 50.3 ± 18.9 | 49.0 ± 18.6 | 0.37 | 0.29 |
HF (n.u.) | 48.3 ± 24.3 | 50.7 ± 29.4 | 0.35 | 41.5 ± 22.5 | 56.1 ± 22.4 | 0.07 | 49.6 ± 18.8 | 50.9 ± 18.5 | 0.38 | 0.29 |
LF:HF ratio | 0.77 [0.46–3.42] | 0.88 [0.28–3.54] | 0.25 | 1.63 [0.99–3.31] | 0.59 [0.35–2.33] | 0.12 | 1.24 [0.56–1.87] | 0.91 [0.61–1.71] | 0.43 | 0.30 |
Total power (ms2) | 802.0 ± 869.7 | 751.8 ± 811.5 | 0.28 | 682.5 ± 714.2 | 675.5 ± 1223.1 | 0.25 | 570.3 ± 718.4 | 514.8 ± 415.8 | 0.78 | 0.78 |
Mean ± SD; median: [percentiles 25–75]); CON – control; HI – high intensity; BFR – blood flow restriction; HR – heart rate; BPM – beats per minute; RR interval – average of all normal R-R intervals; SDNN – standard deviation of all normal NN interval; rMSSD – root- mean of square sucessive NN interval difference; pNN50 – percent of normal-normal NN intervals whose difference exceeds 50 ms; LF – low frequency band; HF – high frequency band; LF:HF ratio – sympathovagal balance; Δ comparisons tested by one-way ANOVA.